Blogopmaak
DCRT supports rare disease day
Members of the DCRT came together to show their support for those 300 million people over the world living with rare diseases and their families. The Dutch Centre of RNA therapy focusses on these patients and specifically on those with ultra rare diseases. We believe anti-sense oligonucleotide therapy could help some of these patients. The photo already gives away that many people are involved in the DCRT consortium. Thank you all for your involvement and support!
published on Feb 23, 2022
Two new DCRT papers have been published online
Team DCRT went for its annual outing to Leiden's escape rooms
N=1 Collaborative is looking for communication trainees
PhD Position in treatment-response fluid biomarkers for ASO treatments
Short report of the 3rd Dutch Antisense Therapeutics Symposium in Rotterdam
DCRT travel grants awarded to 3 PhD students
Dr Marlen Lauffer, a senior researcher at the Dutch Center for RNA Therapeutics, was invited to give a talk at the Genomics England research summit in London on the 9th of July. She presented DCRT's work on the identification of genes and diseases and guidelines for patient selection.
Our paper on patient selection guidelines for ASO-based treatments has been published in Human Mutation!
A special cake for Bianca Zardetto to celebrate the acceptance of her article in Human Mutation
DCRT at the 3rd Dutch Antisense Therapeutics Symposium in Rotterdam